The asthma evidence base: a call for core outcomes in interventional trials

References

• Hekking PPW, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135(4):896–902. doi:10.1016/j.jaci.2014.08.042.
   PubMed Web of Science ®Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–73. doi:10.1183/09031936.00202013.
   PubMed Web of Science ®Google Scholar
• Sullivan PW, Ghushchyan VH, Globe G, Schatz M. Oral corticosteroid exposure and adverse effects in asthmatic patients. J Allergy Clin Immunol. 2018;141(1):110–116.e7. doi:10.1016/j.jaci.2017.04.009.
   PubMed Web of Science ®Google Scholar
• Pandya D, Puttanna A, Balagopal V. Systemic effects of inhaled corticosteroids: An overview. Open Respir Med J. 2014;8:59–65. doi:10.2174/1874306401408010059.
   PubMedGoogle Scholar
• Lee LK, Obi E, Paknis B, Kavati A, Chipps B. Asthma control and disease burden in patients with asthma and allergic comorbidities. J Asthma. 2018;55(2):208–19. doi:10.1080/02770903.2017.1316394.
   PubMed Web of Science ®Google Scholar
• Foster JM, McDonald VM, Guo M, Reddel HK. i have lost in every facet of my life”: The hidden burden of severe asthma. Eur Respir J. 2017;50(3):1700765. doi:10.1183/13993003.00765-2017.
   PubMed Web of Science ®Google Scholar
• Yaghoubi M, Adibi A, Safari A, FitzGerald JM, Sadatsafavi M. The Projected Economic and Health Burden of Uncontrolled Asthma in the United States. Am J Respir Crit Care Med. 2019;200(9):1102–12. doi:10.1164/rccm.201901-0016OC.
   PubMed Web of Science ®Google Scholar
• Bice JB, Leechawengwongs E, Montanaro A. Biologic targeted therapy in allergic asthma. Ann Allergy Asthma Immunol. 2014;112(2):108–15. doi:10.1016/j.anai.2013.12.013.
   PubMed Web of Science ®Google Scholar
• Normansell R, Walker S, Milan SJ, Walters EH, Nair P. Omalizumab for asthma in adults and children. Cochrane Database Syst Rev. 2014;(1):CD003559. doi:10.1002/14651858.CD003559.pub4.
   PubMed Web of Science ®Google Scholar
• Farne HA, Wilson A, Powell C, Bax L, Milan SJ. Anti-IL5 therapies for asthma. Cochrane Database Syst Rev. 2017;9:CD010834. doi:10.1002/14651858.CD010834.pub3.
   PubMed Web of Science ®Google Scholar
• Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, Busse WW, Ford L, Sher L, FitzGerald JM, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med. 2018;378(26):2486–96. doi:10.1056/NEJMoa1804092.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Nair P, Brusselle G, Maspero JF, Castro M, Sher L, Zhu H, Hamilton JD, Swanson BN, Khan A, et al. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N Engl J Med. 2018;378(26):2475–85. doi:10.1056/NEJMoa1804093.
   PubMed Web of Science ®Google Scholar
• Gliklich RE, Castro M, Leavy MB, Press VG, Barochia A, Carroll CL, Harris J, Rittner SS, Freishtat R, Panettieri RA, et al. Harmonized outcome measures for use in asthma patient registries and clinical practice. J Allergy Clin Immunol. 2019;144(3):671–81.e1. doi:10.1016/j.jaci.2019.02.025.
   PubMed Web of Science ®Google Scholar
• Lefebvre C, Glanville J, Briscoe S, Littlewood A, Marshall C, Metzendorf M-I, Noel-Storr A, Rader T, Shokraneh F, Thomas J, et al. Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, eds. Cochrane handbook for systematic reviews of interventions version 6.0. Cochrane; 2019. Available from: www.training.cochrane.org/handbook [last accessed July 2019].
   Google Scholar
• Cochrane Airways. Sources and search methods for the Cochrane Airways Trials Register. 2018. Available from: https://airways.cochrane.org/sites/airways.cochrane.org/files/public/uploads/search_strategies_document_nov_2018.pdf.
   Google Scholar
• Dodd S, Clarke M, Becker L, Mavergames C, Fish R, Williamson PR. A taxonomy has been developed for outcomes in medical research to help improve knowledge discovery. J Clin Epidemiol. 2018;96:84–92. doi:10.1016/j.jclinepi.2017.12.020.
   PubMed Web of Science ®Google Scholar
• Denlinger LC, Phillips BR, Ramratnam S, Ross K, Bhakta NR, Cardet JC, Castro M, Peters SP, Phipatanakul W, Aujla S, et al. Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations. Am J Respir Crit Care Med. 2017;195(3):302–13. doi:10.1164/rccm.201602-0419OC.
   PubMed Web of Science ®Google Scholar
• Fuhlbrigge A, Peden D, Apter AJ, Boushey HA, Camargo CA, Gern J, Heymann PW, Martinez FD, Mauger D, Teague WG, et al. Asthma outcomes: Exacerbations. J Allergy Clin Immunol. 2012;129(3 Suppl):S34–S48. doi:10.1016/j.jaci.2011.12.983.
   PubMed Web of Science ®Google Scholar
• Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, Tugwell P. Developing core outcome sets for clinical trials: Issues to consider. Trials. 2012;13(1):132. doi:10.1186/1745-6215-13-132.
   PubMed Web of Science ®Google Scholar
• Knutsen RM. Drugmakers target severe asthma patients with biologics, but payers raise pricing issue. 2017.
   Google Scholar
• Pavord ID, Beasley R, Agusti A, et al. After asthma: redefining airways diseases. Lancet. 2018;391(10118):350–400. doi:10.1016/S0140-6736(17)30879-6.
   PubMed Web of Science ®Google Scholar
• Biologic Therapies for Treatment of Asthma Associated with Type 2 Inflammation: Effectiveness, Value, and Value-Based Price Benchmarks. Institute for Clinical and Economic Review. Published 2018. Accessed August 9, 2019. https://icer-review.org/wp-content/uploads/2018/04/ICER_Asthma_Draft_Report_092418v1.pdf.
   Google Scholar
• Worth A, Hammersley V, Knibb R, et al. Patient-reported outcome measures for asthma: a systematic review. NPJ Prim Care Respir Med. 2014;24:14020. doi:10.1038/npjpcrm.2014.20.
   PubMed Web of Science ®Google Scholar
• Kocks JWH, Seys SF, van Duin TS, Diamant Z, Tsiligianni IG. Assessing patient-reported outcomes in asthma and COPD patients: which can be recommended in clinical practice?. Curr Opin Pulm Med. 2018;24(1):18–23. doi:10.1097/MCP.0000000000000447.
   PubMed Web of Science ®Google Scholar
• Pocket guide for asthma management and prevention. Accessed October 8, 2019. https://ginasthma.org/wp-content/uploads/2019/04/GINA-2019-main-Pocket-Guide-wms.pdf.
   Google Scholar
• Qualification of Asthma Daytime Symptom Diary and Asthma Nighttime Symptom Diary: Patient-Reported Outcome Instruments for Measurement of Symptoms of Asthma. 2019.
   Google Scholar
• Braido F, Baiardini I, Canonica GW. Patient-reported outcomes in asthma clinical trials. Curr Opin Pulm Med. 2018;24(1):70–7. doi:10.1097/MCP.0000000000000440.
   PubMed Web of Science ®Google Scholar
• McDonald VM, Hiles SA, Jones KA, Clark VL, Yorke J. Health-related quality of life burden in severe asthma. Med J Aust. 2018;209(S2):S28–S33. http://www.ncbi.nlm.nih.gov/pubmed/30453870.
   PubMed Web of Science ®Google Scholar
• Mendez K. ICER can do better for patients. JMCP. 2019;25(5):514–6. doi:10.18553/jmcp.2019.25.5.514.
   PubMed Web of Science ®Google Scholar
• Hyland ME, Lanario JW, Pooler J, Masoli M, Jones RC. How patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma. Health Qual Life Outcomes. 2018;16(1):24. doi:10.1186/s12955-018-0851-9.
   PubMed Web of Science ®Google Scholar
• coreHEM: Developing Comparative Effectiveness Outcomes for Gene Therapy in Hemophilia. Published 2018. Accessed August 9, 2019. http://www.cmtpnet.org/docs/resources/coreHEM_Final_Report_21_MAY_2018.pdf.
   Google Scholar